Granules India Ltd. — Investor Relations & Filings

Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.